ROHAN PALEKAR
CIK 1423327 · Chief Executive Officer · last filed 2026-02-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
60
Lifetime Open-Market Net
-$3.95M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NGNE | Director | — | $29.10 | — | $0 | 4 | 2026-02-24 |
| 89bio, Inc. (ETNB) Delisted | Chief Executive Officer | 0 | $14.84 | $0 | -$1.43M | 31 | 2025-10-30 |
| Neurogene Inc. (NLTX) Delisted | Director | — | $13.96 | — | $0 | 3 | 2023-06-09 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | SVP & Chief Commercial Officer | 302,806 | — | — | -$418.0K | 10 | 2014-11-28 |
| MEDIVATION, INC. (MDVN) Delisted | Chief Commercial Officer | 16,666 | — | — | -$2.10M | 12 | 2011-04-21 |
Recent Filings · Page 4 of 6
60 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-16 | Neurogene Inc. (NLTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-13 | 89bio, Inc. (ETNB) Delisted | Tax (F) | −4,088 | -$21.4K | EDGAR |
| 2022-03-04 | Neurogene Inc. (NLTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-22 | 89bio, Inc. (ETNB) Delisted | Grant (A) | +54,200 | $0 | EDGAR |
| 2022-01-31 | 89bio, Inc. (ETNB) Delisted | Buy (P) | +7,500 | $52.9K | EDGAR |
| 2021-07-08 | 89bio, Inc. (ETNB) Delisted | Buy (P) | +7,000 | $117.8K | EDGAR |
| 2021-02-09 | 89bio, Inc. (ETNB) Delisted | Grant (A) | +30,000 | $0 | EDGAR |
| 2020-02-19 | 89bio, Inc. (ETNB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-11-28 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Mixed | −15,000 | -$225.0K | EDGAR |
| 2014-11-12 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Grant (A) | +94,056 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.